Issue Date | Title | Author(s) |
2019-07-01 | IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis | Starkey, MR; Plank, MW; Casolari, P; Papi, A; Pavlidis, S; Guo, Y; Cameron, GJM; Haw, TJ; Tam, A; Obiedat, M; Donovan, C; Hansbro, NG; Nguyen, DH; Nair, PM; Kim, RY; Horvat, JC; Kaiko, GE; Durum, SK; Wark, PA; Sin, DD; Caramori, G; Adcock, IM; Foster, PS; Hansbro, PM |
2019-01-01 | Group 2 innate lymphoid cells are redundant in experimental renal ischemia-reperfusion injury | Cameron, GJM; Cautivo, KM; Loering, S; Jiang, SH; Deshpande, AV; Foster, PS; McKenzie, ANJ; Molofsky, AB; Hansbro, PM; Starkey, MR |
2019-04-01 | Lung development and emerging roles for type 2 immunity | Loering, S; Cameron, GJM; Starkey, MR; Hansbro, PM |
2022-10 | Airway and parenchymal transcriptomics in a novel model of asthma and COPD overlap. | Tu, X; Kim, RY; Brown, AC; de Jong, E; Jones-Freeman, B; Ali, MK; Gomez, HM; Budden, KF; Starkey, MR; Cameron, GJM; Loering, S; Nguyen, DH; Nair, PM; Haw, TJ; Alemao, CA; Faiz, A; Tay, HL; Wark, PAB; Knight, DA; Foster, PS; Bosco, A; Horvat, JC; Hansbro, PM; Donovan, C |
2020-10-26 | Differences in pulmonary innate lymphoid cells are dependent on mouse age, sex and strain | Loering, S; Cameron, GJM; Bhatt, NP; Belz, GT; Foster, PS; Hansbro, PM; Starkey, MR |
2019 | Lung development and emerging roles for type 2 immunity | HANSBRO, PM; Loering, S; Cameron, GJM; Starkey, MR |
2019-05-01 | Emerging therapeutic potential of group 2 innate lymphoid cells in acute kidney injury | Cameron, GJM; Jiang, SH; Loering, S; Deshpande, AV; Hansbro, PM; Starkey, MR |
2019-01-01 | Roles for T/B lymphocytes and ILC2s in experimental chronic obstructive pulmonary disease | Donovan, C; Starkey, MR; Kim, RY; Rana, BMJ; Barlow, JL; Jones, B; Haw, TJ; Mono Nair, P; Budden, K; Cameron, GJM; Horvat, JC; Wark, PA; Foster, PS; McKenzie, ANJ; Hansbro, PM |